For individuals taking semaglutide, monitoring changes in acid reflux symptoms and adjusting lifestyle choices may be prudent
Whilst off-label prescribing is sometimes appropriate in clinical practice when supported by evidence and clinical judgement, it carries specific responsibilities and risks that both prescribers and patients must carefully consider
Rather than the Mississippi and West Virginia Boards of Pharmacy (BOP) ban the use of semaglutide salt, they banned all forms of semaglutide, even the base version that is the active ingredient in the FDA-approved Ozempic and Wegovy
A comprehensive pre-treatment panel typically includes a Complete Metabolic Panel (CMP) to assess liver and kidney function, a Complete Blood Count (CBC), thyroid function tests (TSH, Free T3, Free T4), fasting glucose and insulin levels, HbA1c, and a lipid panel
If you experience acid reflux symptoms after starting semaglutide, it is crucial to consult with your healthcare provider before making any changes to your medication